Company intelligence / Profile preview

Shanghai Conlighti Medical Laboratory

Shanghai, Shanghai, China

Ownership: Private
Development stage: Other

Overview

In 2016 Conlight launched what it describes as the first genetic testing service for psychiatric drugs in China and has since built the largest psychiatric drug genome database in the country, while also offering IVD products and clinical diagnostic services focused on mental and neurological diseases; no therapeutic drug clinical trials were identified, only commercial diagnostic offerings.

Therapeutic areas: PsychiatryNeurology
Modalities: DeviceDiagnostic testIn vitro diagnostic
Industry: Molecular Diagnostics

Partnerships

ClearSky Medical Diagnostics (strategic cooperation to incubate and commercialize PD-Monitor, an AI-based device for diagnosis and monitoring of Parkinson’s disease in China)

Beyond the preview

Go deeper on Shanghai Conlighti Medical Laboratory.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Shanghai Conlighti Medical Laboratory.

Explore the full profile